Mutational Analysis and Serum Proteomic characterization of patient samples: prelude to the MMRC sponsored trial of the multi targeted kinase inhibitor PKC412 - Regional Cancer Care Associates LLC

Clinical Trials

Mutational Analysis and Serum Proteomic characterization of patient samples: prelude to the MMRC sponsored trial of the multi targeted kinase inhibitor PKC412

Type of Cancer

Warning: implode(): Invalid arguments passed in /home/region33/public_html/wp-content/themes/regionalcancercenter/single-clinical-trials.php on line 42
Locations
Sponsor
MMRC
Protocol Number
MMRC Mutational Tissue Collection
Cancer Diagnosis
To Learn More Call
201-510-0910